Alcohol, the vagus nerve and multi-organ inflammation

酒精、迷走神经和多器官炎症

基本信息

  • 批准号:
    8334496
  • 负责人:
  • 金额:
    $ 19.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-20 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The tenth cranial nerve, the vagus, is distributed throughout the body, including major divisions to all parts of the gut, and to the liver. This cholinergic nerve restrains inflammation, in all the organs to which the vagus is distributed, by the tonic release of acetylcholine (ACh) onto nicotinic receptors (nicAChRs) of the alpha7- subtype. In addition to their presence on inflammatory cells, alpha7-nicAChRs are also present on cell bodies of the vagus in the CNS, where they cause vagal activation and neuroprotection. Since the presence of alcohol inhibits alpha7-nicAChRs, and a known chronic effect is to cause vagal neuropathy, these anti-inflammatory effects of the vagus are seriously compromised during alcohol exposure. The primary hypothesis is that this reduced vagal function contributes to the chronic inflammation following oxidative stress, which is a common feature of alcohol-induced damage in many organs. If correct, this predicts that compounds with alpha7- nicAChR agonist properties will protect against alcohol-induced tissue damage, particularly if these compounds are also anti-oxidants. The first specific aim of this proposal is to test the primary hypothesis in vitro by studying the interactions of alcohol and alpha7-nicAChR ligands on endotoxin-induced release of mediators from inflammatory cells (splenic, lung and peritoneal macrophages) from wild-type, and alpha7-nicAChR knock-out, C57Bl/6J mice. The second specific aim is to test the hypothesis in vivo by exposing C57Bl/6J mice (wild-type, vagotomized, and alpha7-nicAChR knockouts) chronically to alcohol by forced consumption, and then evaluating endotoxin-induced release of inflammatory mediators in vivo. As part of these studies we will evaluate the therapeutic potential of the alpha7-nicAChR agonist, choline, and a methylquercetagetin which acts as a partial agonist at alpha7-nicAChRs. The latter was recently discovered by screening a native plant extract library, and has potent anti-oxidant activity in addition to its action at nicAChRs, where it has an affinity comparable to choline. The ability of these compounds to inhibit endotoxin-induced release of inflammatory mediators following alcohol exposure will be studied in vitro and in vivo using the same methods as above. This project therefore tests a novel hypothesis for alcohol-induced organ damage based on the interaction between brain, gut and liver as represented by the vagus nerve, and tests a novel therapeutic approach to this.
描述(由申请人提供):第十脑神经,迷走神经,分布于全身,包括肠道所有部分和肝脏的主要分支。这种胆碱能神经通过将乙酰胆碱(ACh)紧张性释放到α 7亚型的烟碱受体(nicAChR)上来抑制迷走神经分布的所有器官中的炎症。除了它们存在于炎性细胞上之外,α 7-nicAChR还存在于CNS中迷走神经的细胞体上,在那里它们引起迷走神经激活和神经保护。由于酒精的存在抑制α 7-nicAChR,并且已知的慢性效应是引起迷走神经病变,因此迷走神经的这些抗炎作用在酒精暴露期间严重受损。主要的假设是,这种迷走神经功能的降低有助于氧化应激后的慢性炎症,这是许多器官中酒精诱导损伤的共同特征。如果正确的话,这预示着具有α 7- nicAChR激动剂特性的化合物将防止酒精诱导的组织损伤,特别是如果这些化合物也是抗氧化剂。本提案的第一个具体目的是通过研究酒精和α 7-nicAChR配体对来自野生型和α 7-nicAChR敲除C57 Bl/6 J小鼠的炎性细胞(脾、肺和腹膜巨噬细胞)的内毒素诱导的介质释放的相互作用,在体外检验主要假设。第二个具体目标是通过强迫消费将C57 Bl/6 J小鼠(野生型、迷走神经切断和α 7-nicAChR敲除)长期暴露于酒精,然后评估内毒素诱导的体内炎症介质释放,从而在体内检验该假设。作为这些研究的一部分,我们将评估α 7-nicAChR激动剂胆碱和甲基槲皮素的治疗潜力,甲基槲皮素作为α 7-nicAChR的部分激动剂。后者是最近通过筛选天然植物提取物库发现的,并且除了其对nicAChR的作用之外还具有有效的抗氧化活性,其中它具有与胆碱相当的亲和力。将使用与上述相同的方法在体外和体内研究这些化合物抑制酒精暴露后内毒素诱导的炎症介质释放的能力。因此,该项目基于以迷走神经为代表的大脑、肠道和肝脏之间的相互作用,测试了酒精引起的器官损伤的新假设,并测试了一种新的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN M. LITTLETON其他文献

JOHN M. LITTLETON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN M. LITTLETON', 18)}}的其他基金

Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads
模拟植物细胞中的突触核蛋白毒性以鉴定新型神经保护先导化合物
  • 批准号:
    10267035
  • 财政年份:
    2018
  • 资助金额:
    $ 19.98万
  • 项目类别:
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads
模拟植物细胞中的突触核蛋白毒性以鉴定新型神经保护先导化合物
  • 批准号:
    10078986
  • 财政年份:
    2018
  • 资助金额:
    $ 19.98万
  • 项目类别:
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
开发 JR-220(4-氯苯亚基氨基胍盐酸盐)作为酒精依赖药物
  • 批准号:
    10459072
  • 财政年份:
    2017
  • 资助金额:
    $ 19.98万
  • 项目类别:
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
开发 JR-220(4-氯苯亚基氨基胍盐酸盐)作为酒精依赖药物
  • 批准号:
    9397465
  • 财政年份:
    2017
  • 资助金额:
    $ 19.98万
  • 项目类别:
Mutant transgenic plant cells as a novel source of drugs
突变转基因植物细胞作为新的药物来源
  • 批准号:
    9253077
  • 财政年份:
    2016
  • 资助金额:
    $ 19.98万
  • 项目类别:
Mutant transgenic plant cells as a novel source of drugs
突变转基因植物细胞作为新的药物来源
  • 批准号:
    9356446
  • 财政年份:
    2016
  • 资助金额:
    $ 19.98万
  • 项目类别:
Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles
使用磁化纳米颗粒从毛状根培养物中收获特定的植物代谢物
  • 批准号:
    9343261
  • 财政年份:
    2014
  • 资助金额:
    $ 19.98万
  • 项目类别:
Harvesting specific plant metabolites from hairy root cultures using magnetized n
使用磁化n从毛状根培养物中收获特定的植物代谢物
  • 批准号:
    8712853
  • 财政年份:
    2014
  • 资助金额:
    $ 19.98万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 19.98万
  • 项目类别:
Alcohol, the vagus nerve and multi-organ inflammation
酒精、迷走神经和多器官炎症
  • 批准号:
    8064072
  • 财政年份:
    2011
  • 资助金额:
    $ 19.98万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 19.98万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了